Psychopharmacology Committee

The purpose of the Psychopharmacology Committee of the Group for the Advancement of Psychiatry is to advance the understanding and use of psychopharmacology in the treatment of mental illness.

The committee's work is guided by the following principles:

• The use of psychotropic medications should be based on sound scientific evidence.

• Patients should be informed about the benefits and risks of psychotropic medications before they are prescribed.

• Psychotropic medications should be used in conjunction with other treatment modalities, such as psychotherapy, when possible.

• The use of psychotropic medications should be monitored closely to ensure that they are effective and safe.

The committee believes that psychopharmacology can be a valuable tool in the treatment of mental illness. However, the committee also recognizes that psychotropic medications can have risks, and that they should not be used without careful consideration of the individual patient's needs. The committee is committed to promoting the responsible use of psychotropic medications in order to improve the lives of people with mental illness.